TY - JOUR
T1 - Sexual harassment and gender discrimination in gynecologic oncology
AU - Stasenko, Marina
AU - Tarney, Christopher
AU - Seier, Kenneth
AU - Casablanca, Yovanni
AU - Brown, Carol L.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/11
Y1 - 2020/11
N2 - Objective: To determine the prevalence of sexual harassment and perceptions of gender disparities affecting the careers of physicians in gynecologic oncology. Methods: We conducted a survey of US physician members of the Society of Gynecologic Oncology. Participants were queried about demographics, sexual harassment experiences during training/practice, and perceptions of gender disparities in compensation and career advancement. Responses were categorized as “never” versus “ever” and compared using Fisher's exact test. Results: The survey was sent to 1566 members—405 (255 females, 147 males, 3 other) responded (response rate 26%). Sixty-four percent reported having experienced sexual harassment during training/practice. Sexual harassment was experienced by 71% of females and 51% of males. Of these respondents, only 14.5% reported it. Reasons for not reporting included: “incident did not seem important enough” (40%); “did not think anything would be done about it” (37%); and “fear of reprisal” (34%). Female respondents were more likely to report gender affected their career advancement (34% vs. 10%; p ≤.001) and compensation (64% vs. 19%; p ≤.001); males were more likely to report no gender income disparity (91% vs. 57%; p ≤.001). Conclusions: Sexual harassment during training/practice appears common among male and female gynecologic oncologists. Although most are aware of how to report an incident, few do so, mostly for fear of reprisal or concern nothing will be done. Despite practicing in a field defined by caring for women, female physicians more often perceive gender influences their compensation and career advancement. Awareness of these issues can lead to their elimination from our specialty.
AB - Objective: To determine the prevalence of sexual harassment and perceptions of gender disparities affecting the careers of physicians in gynecologic oncology. Methods: We conducted a survey of US physician members of the Society of Gynecologic Oncology. Participants were queried about demographics, sexual harassment experiences during training/practice, and perceptions of gender disparities in compensation and career advancement. Responses were categorized as “never” versus “ever” and compared using Fisher's exact test. Results: The survey was sent to 1566 members—405 (255 females, 147 males, 3 other) responded (response rate 26%). Sixty-four percent reported having experienced sexual harassment during training/practice. Sexual harassment was experienced by 71% of females and 51% of males. Of these respondents, only 14.5% reported it. Reasons for not reporting included: “incident did not seem important enough” (40%); “did not think anything would be done about it” (37%); and “fear of reprisal” (34%). Female respondents were more likely to report gender affected their career advancement (34% vs. 10%; p ≤.001) and compensation (64% vs. 19%; p ≤.001); males were more likely to report no gender income disparity (91% vs. 57%; p ≤.001). Conclusions: Sexual harassment during training/practice appears common among male and female gynecologic oncologists. Although most are aware of how to report an incident, few do so, mostly for fear of reprisal or concern nothing will be done. Despite practicing in a field defined by caring for women, female physicians more often perceive gender influences their compensation and career advancement. Awareness of these issues can lead to their elimination from our specialty.
KW - Gender discrimination
KW - Gynecologic oncologists
KW - Gynecologic oncology
KW - Income disparity
KW - Sexual harassment
UR - http://www.scopus.com/inward/record.url?scp=85089754275&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2020.08.014
DO - 10.1016/j.ygyno.2020.08.014
M3 - Article
C2 - 32839027
AN - SCOPUS:85089754275
SN - 0090-8258
VL - 159
SP - 317
EP - 321
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -